Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gail Boudreaux currently holds 12,192 shares of GENZYME CORP (GENZ), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gail Boudreaux has been a net seller of GENZ stock. They have purchased $5.2M and sold $42.6M worth of shares.
Gail Boudreaux's most recent insider trade was on Mar 11, 2026, when they sold 2,682 shares at $0.00 per share.
Gail Boudreaux serves as Executive at GENZYME CORP (GENZ). They have executed 137 insider transactions totaling $47.8M over their tenure at the company.
Gail Boudreaux holds the position of Executive at GENZYME CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Gail Boudreaux has shown a selling trading pattern, with $5.2M in total purchases and $42.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Gail Boudreaux was on Mar 1, 2021, when they sold $11.1M worth of ANTM shares. This transaction involved 35,564 shares at $311.48 per share.
Gail Boudreaux currently owns 12,192 shares of GENZYME CORP (GENZ), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gail Boudreaux's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gail Boudreaux has 137 Form 4 filings on record as an insider at GENZYME CORP.
Set alerts for Gail Boudreaux and 40,000+ other insiders.